KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) EBT (2016 - 2025)

Chemed (CHE) has 17 years of EBT data on record, last reported at $105.4 million in Q4 2025.

  • For Q4 2025, EBT fell 12.22% year-over-year to $105.4 million; the TTM value through Dec 2025 reached $355.8 million, down 10.94%, while the annual FY2025 figure was $355.8 million, 10.94% down from the prior year.
  • EBT reached $105.4 million in Q4 2025 per CHE's latest filing, up from $83.5 million in the prior quarter.
  • Across five years, EBT topped out at $120.1 million in Q4 2024 and bottomed at $70.3 million in Q2 2023.
  • Average EBT over 5 years is $89.3 million, with a median of $85.4 million recorded in 2022.
  • Peak YoY movement for EBT: crashed 34.09% in 2021, then surged 40.28% in 2023.
  • A 5-year view of EBT shows it stood at $96.1 million in 2021, then dropped by 14.28% to $82.4 million in 2022, then surged by 40.28% to $115.6 million in 2023, then grew by 3.92% to $120.1 million in 2024, then decreased by 12.22% to $105.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBT were $105.4 million in Q4 2025, $83.5 million in Q3 2025, and $71.1 million in Q2 2025.